Sensus Healthcare Reports Third Quarter 2020 Financial Results
Conference call begins at 4:30 p.m. Eastern time todayBOCA RATON, Fla., Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological...
Sensus Healthcare Appoints Megan Cornish to its Board of Directors
Gains valuable Capitol Hill, business strategy and marketing experience BOCA RATON, Fla, Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments...
Sensus Healthcare to Host Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020
BOCA RATON, Fla. , Oct. 29, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on...
Sensus Healthcare Announces Publication of Study Showing Use of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence
Keloid recurrence rate of 10.4% at 12 months for patients treated with SRT following keloidectomy compares with more than 80% with surgical excision aloneRetrospective study published in Journal of Clinical and Aesthetic Dermatology BOCA RATON, Fla., Oct. 22, 2020 --...
Sensus Healthcare Reports Second Quarter 2020 Financial Results
Conference call begins at 4:30 p.m. Eastern time todayBOCA RATON, Fla., Aug. 06, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological...